Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,612,450 | 2,369,100 | 2,818,000 | 2,988,490 | 2,432,300 |
| Marketable Securities | 901,340 | 866,270 | 508,000 | 499,650 | 839,020 |
| Receivables | 2,898,810 | 2,863,820 | 3,193,000 | 3,590,010 | 3,319,110 |
| Inventories | 1,493,880 | 1,400,630 | 1,364,000 | 1,478,270 | 1,423,880 |
| Other current assets | 1,025,350 | 1,045,550 | 917,000 | 1,303,850 | 1,272,120 |
| TOTAL | $8,931,830 | $8,545,370 | $8,800,000 | $9,860,270 | $9,286,430 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 5,884,000 | N/A | N/A |
| Investments And Advances | 650,150 | 655,410 | 666,000 | 708,250 | 751,150 |
| Other Non-Current Assets | 3,327,280 | 3,453,760 | 3,588,000 | 4,316,520 | 4,184,240 |
| TOTAL | $3,977,430 | $4,109,170 | $10,138,000 | $5,024,770 | $4,935,390 |
| Total Assets | $15,120,930 | $14,857,770 | $15,378,000 | $17,442,370 | $16,757,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,094,640 | 1,077,040 | 2,027,000 | 1,422,710 | 1,115,930 |
| Accrued Expenses | N/A | N/A | 1,052,000 | N/A | N/A |
| Other current liabilities | 2,012,660 | 2,126,200 | 256,000 | 2,025,040 | 1,922,410 |
| TOTAL | $3,107,320 | $3,203,250 | $3,335,000 | $3,636,980 | $3,216,440 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 674,860 | 652,700 | 376,000 | 875,290 | 799,210 |
| TOTAL | $674,860 | $652,700 | $745,000 | $875,290 | $799,210 |
| Total Liabilities | $3,782,180 | $3,855,960 | $4,080,000 | $4,512,290 | $4,015,660 |
| Shareholders' Equity | |||||
| Common Shares | 1,040,300 | 1,040,300 | 1,096,000 | 1,266,900 | 1,308,100 |
| Retained earnings | 8,978,450 | 8,715,490 | 9,761,000 | 11,307,520 | 11,710,750 |
| Other shareholders' equity | -215,910 | -288,880 | -671,000 | -1,295,250 | -2,229,580 |
| TOTAL | $11,338,730 | $11,001,800 | $11,298,000 | $12,930,060 | $12,741,890 |
| Total Liabilities And Equity | $15,120,910 | $14,857,760 | $15,378,000 | $17,442,350 | $16,757,550 |